SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-23-004983
Filing Date
2023-10-19
Accepted
2023-10-19 10:36:53
Documents
11
Period of Report
2023-10-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea186957-6k_purplebio.htm 6-K 20305
2 FORM OF SECURITIES PURCHASE AGREEMENT ea186957ex4-1_purplebio.htm EX-4.1 238338
3 FORM OF PRE-FUNDED WARRANT ea186957ex4-2_purplebio.htm EX-4.2 90255
4 FORM OF WARRANT ea186957ex4-3_purplebio.htm EX-4.3 100124
5 FORM OF AMENDMENT TO EXISTING WARRANTS ea186957ex4-4_purplebio.htm EX-4.4 9398
6 FORM OF PLACEMENT AGENT WARRANT ea186957ex4-5_purplebio.htm EX-4.5 98200
7 OPINION OF FISCHER (FBC & CO.) ea186957ex5-1_purplebio.htm EX-5.1 11372
8 OPINION OF HAYNES AND BOONE, LLP ea186957ex5-2_purplebio.htm EX-5.2 13617
9 GRAPHIC ex5-1_001.jpg GRAPHIC 12835
10 GRAPHIC ex5-1_002.jpg GRAPHIC 11993
11 GRAPHIC ex5-2_001.jpg GRAPHIC 2686
  Complete submission text file 0001013762-23-004983.txt   621133
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 231333732
SIC: 2834 Pharmaceutical Preparations